The impact of methylprednisolone on lesion severity following spinal cord injury

Spine

Volumn 32, Issue 3, 2007, Pages 373-378

  Leypold, Bradley G ^a   Flanders, Adam E ^a   Schwartz, Eric D ^b   Burns, Anthony S ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Acute spinal cord injury; Magnetic resonance imaging; Methylprednisolone; Spinal cord edema; Spinal cord hemorrhage

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; EDEMA; FEMALE; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; SPINAL CORD HEMORRHAGE; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPINAL CORD INJURIES;

EID: 33846680373     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000253964.10701.00     Document Type: Article

References (41)

1. National Spinal Cord Injury Statistical Center. Spinal Cord Injury: Facts and Figures at a Glance (www.spinalcord.uab.edu). Birmingham, AL: University of Alabama (Accessed June 2, 2005).
2. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15-26.
3. Bunge RP, Puckett WR, Becerra JL, et al. Observations on the pathology of human spinal cord injury: a review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993;59:75-89.
4. Quencer RM, Bunge RP. The injured spinal cord: imaging, histopathologic clinical correlates, and basic science approaches to enhancing neural function after spinal cord injury. Spine 1996;21:2064-6.
5. Croul SE, Flanders AE. Neuropathology of human spinal cord injury. Adv Neurol 1997;72:317-23.
6. Kakulas BA. Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 2004;42:549-63.
7. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15-26.
8. Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 1999;44:1027-39; discussion 1039-40.
9. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405-11.
10. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277:1597-604.
11. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992;76:23-31.
12. Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998;89:699-706.
13. Hall ED. The effects of glucocorticoid and nonglucocorticoid steroids on acute neuronal degeneration. Adv Neurol 1993;59:241-8.
14. Hall ED. The neuroprotective pharmacology of methylprednisolone. J Neurosurg 1992;76:13-22.
15. Nesathurai S. Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 1998;45:1088-93.
16. Bracken MB. Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. Spine 2001;26(suppl):47-54.
17. Hurlbert RJ. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine 2001;26(suppl):39-46.
18. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000;93:1-7.
19. Hurlbert RJ, Moulton R. Why do you prescribe methylprednisolone for acute spinal cord injury? A Canadian perspective and a position statement. Can J Neurol Sci 2002;29:236-9.
20. Bracken MB, Holford TR. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III. J Neurosurg 2002;96:259-66.
21. Bracken MB. Methylprednisolone and spinal cord injury. J Neurosurg 2000;93:175-9.
22. Bracken MB. Steroids for acute spinal cord injury [update of Cochrane Database Syst Rev. 2000;(2):CD001046;
23. Cochrane Database Syst Rev 2002;CD001046.
24. Short DJ, El Masry WS, Jones PW. High dose methylprednisolone in the management of acute spinal cord injury: a systematic review from a clinical perspective. Spinal Cord 2000;38:273-86.
25. Coleman WP, Benzel D, Cahill DW, et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 2000;13:185-99.
26. Qian T, Guo X, Levi AD, et al. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 2005;43:199-203.
27. Qian T, Campagnolo D, Kirshblum S. High-dose methylprednisolone may do more harm for spinal cord injury. Med Hypotheses 2000;55:452-3.
28. Quencer RM. Advances in imaging of spinal cord injury: implications for treatment and patient evaluation. Prog Brain Res 2002;137:3-8.
29. Schaefer DM, Flanders A, Northrup BE, et al. Magnetic resonance imaging of acute cervical spine trauma: correlation with severity of neurologic injury. Spine 1989;14:1090-5.
30. Flanders AE, Spettell CM, Tartaglino LM, et al. Forecasting motor recovery after cervical spinal cord injury: value of MR imaging. Radiology 1996;201:649-55.
31. American Spinal Injury Association. International Standards for Neurological Classification for Spinal Cord Injury (revised 2000, reprinted 2002). Chicago: American Spinal Injury Association, 2002.
32. Liang HW, Wang YH, Lin YN, et al. Impact of age on the injury pattern and survival of people with cervical cord injuries. Spinal Cord 2001;39:375-80.
33. Kannus P, Niemi S, Palvanen M, et al. Continuously increasing number and incidence of fall-induced, fracture-associated, spinal cord injuries in elderly persons. Arch Intern Med 2000;160:2145-9.
34. Kiwerski JE. Injuries to the spinal cord in elderly patients. Injury 1992;23:397-400.
35. Weingarden SI, Graham PM. Falls resulting in spinal cord injury: patterns and outcomes in an older population. Paraplegia 1989;27:423-7.
36. Taoka Y, Okajima K, Uchiba M, et al. Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-alpha production. J Neurotrauma 2001;18:533-43.
37. Means ED, Anderson DK, Waters TR, et al. Effect of methylprednisolone in compression trauma to the feline spinal cord. J Neurosurg 1981;55:200-8.
38. Campbell JB, DeCrescito V, Tomasula JJ, et al. Effects of antifibrinolytic and steroid therapy on the contused spinal cord of cats. J Neurosurg 1974;40:726-33.
39. Koyanagi I, Tator CH. Effect of a single huge dose of methylprednisolone on blood flow, evoked potentials, and histology after acute spinal cord injury in the rat. Neurol Res 1997;19:289-99.
40. Jones KM, Mulkern RV, Mantello MT, et al. Brain hemorrhage: evaluation with fast spin-echo and conventional dual spin-echo images. Radiology 1992;182:53-8.
41. Flanders AE, Tartaglino LM, Friedman DP, et al. Application of fast spin-echo MR imaging in acute cervical spine injury (SCI). Radiology 1992;185:220.